Treatment Decisions for Patients With Melanoma

Omid Hamid, MD, chief, translational research and immunotherapy, director, cutaneous oncology and melanoma, The Angeles Clinic and Research Institute, discusses treatment decisions for patients with melanoma.

Clinical Pearls

Omid Hamid, MD, chief, translational research and immunotherapy, director, cutaneous oncology and melanoma, The Angeles Clinic and Research Institute, discusses treatment decisions for patients with melanoma.

  • When necessary, physicians should refer a patient for a second opinion
  • Physicians must research the benefits of immunotherapy and the kinetics of response
  • Physicians should not follow a treatment recommendation without considering their own clinical experience and the desires of the patient